MedTrace Logo

The Treatment of Cartilaginous Lesions and Concomitant Anterior Cruciate Ligament Reconstruction

NCT04184687 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2026-05-22

No results posted yet for this study

Summary

The aim of the study is the evaluation of both clinical and radiological results in patients undergone to cruciate ligament reconstruction with concomitant cartilaginous lesion treated with or without nanofractures.

Conditions

  • Cruciate Ligament Rupture
  • Cartilage Injury

Interventions

PROCEDURE

Nanofractures

anterior cruciate ligament reconstruction will be performed in combination with the nanofractures for the treatment of cartilaginous lesions

PROCEDURE

no treatment cartilaginous lesions

patient undergoing to the anterior cruciate ligament reconstruction without treatment of the cartilaginous lesions

Sponsors & Collaborators

  • Istituto Ortopedico Rizzoli

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-25
Primary Completion
2023-10-10
Completion
2023-10-10

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04184687 on ClinicalTrials.gov